H. Engler

发表

Enhancement of intravesical delivery with Syn3 potentiates interferon-alpha2b gene therapy for superficial bladder cancer.

R. Connor, W. Benedict, S. Wen, 2007, Cytokine & growth factor reviews.

High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine

S. Rosenfeld, A. Barrett, R. Childs, 1998, Bone Marrow Transplantation.

Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy.

C. Scheibenbogen, W. Brugger, R. Andreesen, 1990, Cancer research.

Early reactivation of cytomegalovirus and high risk of interstitial pneumonitis following T-depleted BMT for adults with hematological malignancies.

A. Barrett, C. Dunbar, C. Dunbar, 1996, Bone Marrow Transplantation.

Interferon α2b gene delivery using adenoviral vector causes inhibition of tumor growth in xenograft models from a variety of cancers

G. Demers, J. Howe, B. Sugarman, 2001, Cancer Gene Therapy.

p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirus.

H. Shepard, H. Engler, Duane E. Johnson, 1998, Clinical Cancer Research.

Successful therapy of sarcoidosis-associated thrombocytopenia refractory to corticosteroids by a single course of human gammaglobulins

R. Engelhardt, G. Löhr, M. Henke, 1986, Klinische Wochenschrift.

A recombinant adenoviral vector expressing full-length human retinoblastoma susceptibility gene inhibits human tumor cell growth.

G. Demers, L. Nielsen, S. Wen, 1998, Cancer gene therapy.

A new approach to adoptive immunotherapy of cancer using tumorcytotoxic macrophages grown from peripheral blood monocytes.

C. Scheibenbogen, W. Brugger, R. Andreesen, 1991, Cancer Detection and Prevention.